Gabapentin recalls

The FDA has published 22 recalls involving Gabapentin since 2013. The latest was reported on 29 Oct 2025. The Harvard Drug Group has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls22since 2013
Last 12 months2reported
Class I00% of total
Ongoing7latest 29 Oct 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 15 68%Class III 7 32%

By year

Ongoing gabapentin recalls

7 active

All gabapentin recalls, newest first

22 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIGabapentin Capsules, USP, 100 mg ( blister packs) recalledThe Harvard Drug GroupPotency & AssayNationwide
DrugCLASS IIGabapentin Capsules, USP, 100 mg ( blister pack) recalledGabapentinThe Harvard Drug GroupPotency & AssayNationwide
DrugCLASS IIGabapentin Capsules, USP, 100 mg recalled by The Harvard Drug GroupGabapentinThe Harvard Drug GroupPackaging DefectsNationwide
DrugCLASS IIGabapentin Capsules, USP, 100 mg , blister pack recalledThe Harvard Drug GroupPackaging DefectsNationwide
DrugCLASS IIIGabapentin Capsules, USP 300 mg recalledGabapentinSUN Pharmaceutical IndustriesPackaging DefectsNationwide
DrugCLASS IIIGabapentin Capsules, USP 400 mg recalledGabapentinSUN Pharmaceutical IndustriesPackaging DefectsNationwide
DrugCLASS IIGabapentin Tablets 600mg recalled by Glenmark PharmaceuticalsGabapentinGlenmark Pharmaceuticals Inc., USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIGabapentin Tablets, USP, 600 mg recalled by Granules PharmaceuticalsGabapentinGranules PharmaceuticalsOtherNationwide
DrugCLASS IIIGabapentin Tablets, USP 600 mg recalled by The Harvard Drug GroupGabapentinThe Harvard Drug GroupPackaging DefectsNationwide
DrugCLASS IIIGabapentin Tablets, USP 600 mg recalled by Sciegen PharmaceuticalsGabapentinSciegen PharmaceuticalsOtherNationwide
DrugCLASS IIGabapentin Oral Solution, 250 mg/ per unit dose cup recalled by AkornAkornPotency & AssayNationwide
DrugCLASS IIIGabapentin Tablets USP, 600 mg recalled by InvaGen PharmaceuticalsGabapentinInvaGen PharmaceuticalsPotency & AssayNationwide
DrugCLASS IIGabapentin Capsules, USP 100mg recalled by Aurobindo Pharma USAGabapentinAurobindo Pharma USAManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIGabapentin Capsules, USP 100 mg recalled by AuroMedics PharmaAuroMedics PharmaOtherNationwide
DrugCLASS IIGabapentin Tablets, USP, 800 mg recalled by Solco Healtcare USSolco Healtcare USPackaging DefectsOH
DrugCLASS IIIGabapentin Oral Solution, 250 mg/ (50 mg/mL) in a amber-colored recalledAkornManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIGabapentin Capsules, USP 300 mg recalled by Aurobindo Pharma USAGabapentinAurobindo Pharma USAPackaging DefectsNationwide
DrugCLASS IIGabapentin Capsules, USP, 100 mg recalled by Actavis ElizabethGabapentinActavis ElizabethOtherPR
DrugCLASS IIGabapentin Capsules, USP, 400 mg recalled by Actavis ElizabethGabapentinActavis ElizabethOtherPR
DrugCLASS IIGabapentin Capsules, USP, 300 mg recalled by Actavis ElizabethGaba 300-ezsActavis ElizabethOtherPR
DrugCLASS IIGabapentin, Tablet, 600 mg recalled by Aidapak ServicesAidapak ServicesLabeling Errors4 states
DrugCLASS IIIGlenmark Gabapentin Tablets, a) 600mg bottle recalledGabapentinGlenmark Generics Inc. USAOtherNationwide

Should you stop taking Gabapentin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.